The stock is now down more than 25% for the year and more than 80% from its all-time high, set earlier this year. With that kind of decline, some investors may wonder if it's a stock with some value ...

Sebi recently issued a circular allowing Indian mutual funds to invest in foreign mutual funds or unit trusts that have ...

Halozyme Therapeutics (NASDAQ:HALO) announced on Thursday its plans to acquire German drug developer Evotec SE ADR ...

Investors looking to buy a potential AI winner trading at a reasonable valuation should consider taking a closer look at this company.